Bisphosphonates in the treatment of skeletal metastases

被引：30
作者：
Conte, P
Coleman, R
机构：
[1] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
[2] Weston Pk Hosp, Canc Res Ctr, Yorkshire Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
来源：
SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2004.07.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 63
页数：5
相关论文
共 46 条
[1]   Extended safety profile of oral clodronate after long-term use in primary breast cancer patients [J].
Atula, S ;
Powles, T ;
Paterson, A ;
McCloskey, E ;
Nevalainen, J ;
Kanis, J .
DRUG SAFETY, 2003, 26 (09) :661-671
[2]   Dosing regimens and main adverse events of bisphosphonates [J].
Body, JJ .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :49-53
[3]   Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies [J].
Body, JJ ;
Diel, IJ ;
Lichinitzer, M ;
Lazarev, A ;
Pecherstorfer, M ;
Bell, R ;
Tripathy, D ;
Bergstronn, B .
BRITISH JOURNAL OF CANCER, 2004, 90 (06) :1133-1137
[4]   Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases [J].
Body, JJ ;
Diel, IJ ;
Lichinitser, MR ;
Kreuser, ED ;
Dornoff, W ;
Gorbunova, VA ;
Budde, M ;
Bergström, B .
ANNALS OF ONCOLOGY, 2003, 14 (09) :1399-1405
[5]   A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease [J].
Castel, LD ;
Bajwa, K ;
Markle, JP ;
Timbie, JW ;
Zacker, C ;
Schulman, KA .
SUPPORTIVE CARE IN CANCER, 2001, 9 (07) :545-551
[6]  
Coleman R E, 2000, Oncologist, V5, P463, DOI 10.1634/theoncologist.5-6-463
[7]   Metastatic bone disease: clinical features, pathophysiology and treatment strategies [J].
Coleman, RE .
CANCER TREATMENT REVIEWS, 2001, 27 (03) :165-176
[8]   Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298 [J].
Coxon, FP ;
Helfrich, MH ;
Van't Hof, R ;
Sebti, S ;
Ralston, SH ;
Hamilton, A ;
Rogers, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1467-1476
[9]  
Delea T, 2004, BONE, V34, pS86
[10]  
Diel I J, 2000, Clin Breast Cancer, V1, P43, DOI 10.3816/CBC.2000.n.003
12345